Jacopo Angelini

13PUBLICATIONS
31CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Nanotoxicology, health and safetyPharmaceutical delivery technologiesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 27, 2026
Real-World Experience on the Use of Eravacycline at Doses of 1 mg/kg Bodyweight and Fixed Dose Strategy in Two European Tertiary Centers.

|Mar 13, 2026
Current opinion on the potential role of liposomal amphotericin B in underexplored clinical scenarios.

Jacopo Angelini, Sara Ferin, Luca Martini

|Feb 27, 2026
Perioperative Management of Biologic and Targeted Synthetic DMARDs in Orthopedic Surgery: Balancing Infection Risk and Disease Control.

Francesco Mancuso, Jacopo Angelini, Alen Zabotti

|Aug 07, 2025
Precision Daptomycin Dosing: Comparison of 3-, 2-, 1-, and 0-Concentration Sample Strategies.

Simone Giuliano, Manjunath P Pai, Jacopo Angelini

|Jun 25, 2025
Oral P2Y<sub>12</sub> Inhibitors: Victims or Perpetrators? A Focused Review on Pharmacokinetic, Clinically Relevant Drug Interactions.

Elisabetta Bigagli, Jacopo Angelini, Alessandro Mugelli

|Feb 26, 2025
PK/PD Analysis of High-Dose Daptomycin Use in the Treatment of Bone and Joint Infections: Data from a Real-World Setting.

Jacopo Angelini, Simone Giuliano, Francesco Russiani

Pageof 3

Frequent Collaborators

5 joint publications

Simone Giuliano

4 joint publications

Massimo Baraldo

4 joint publications

Carlo Tascini

3 joint publications

Luca Martini